Recapping the quarters beginning October 1, 2019 through March 31, 2020, the UConn School of Pharmacy congratulates the following Department of Pharmaceutical Sciences and Pharmacy Practice faculty and their teams for their research grant awards* totaling $6,002,715 :<\/p>\n
Department of Pharmaceutical Sciences:<\/strong><\/p>\n Robin H. Bogner, Ph.D. Xiuling Lu, Ph.D. Xiuling Lu, Ph.D. Diane J. Burgess, Ph.D. Raman Bahal, Ph.D. Diane J. Burgess, Ph.D. Brian J. Aneskievich, Ph.D. Matthew Kyle Hadden, Ph.D. Dennis Wright, Ph.D. Diane J. Burgess, Ph.D. Department of Pharmacy Practice:<\/strong><\/p>\n Craig Coleman, Pharm.D. Nathaniel M. Rickles, Pharm.D., Ph.D. * Grant awards listed in the OVPR Quarterly Reports are those reported as fully executed.<\/p>\n","protected":false},"excerpt":{"rendered":" Recapping the quarters beginning October 1, 2019 through March 31, 2020, the UConn School of Pharmacy congratulates the following Department of Pharmaceutical Sciences and Pharmacy Practice faculty and their teams for their research grant awards* totaling $6,002,715 : Department of Pharmaceutical Sciences: Robin H. Bogner, Ph.D. MedImmune Identifying the Causes for Long Reconstitution Times: Phase […]<\/p>\n","protected":false},"author":126,"featured_media":157578,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_crdt_document":"","wds_primary_category":0,"wds_primary_series":0,"wds_primary_attribution":0,"footnotes":""},"categories":[2076,1864],"tags":[],"magazine-issues":[],"coauthors":[2124],"class_list":["post-158417","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-research","category-pharm"],"pp_statuses_selecting_workflow":false,"pp_workflow_action":"current","pp_status_selection":"publish","acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-04-26 02:23:11","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/today.uconn.edu\/wp-rest\/wp\/v2\/posts\/158417","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/today.uconn.edu\/wp-rest\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/today.uconn.edu\/wp-rest\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/today.uconn.edu\/wp-rest\/wp\/v2\/users\/126"}],"replies":[{"embeddable":true,"href":"https:\/\/today.uconn.edu\/wp-rest\/wp\/v2\/comments?post=158417"}],"version-history":[{"count":0,"href":"https:\/\/today.uconn.edu\/wp-rest\/wp\/v2\/posts\/158417\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/today.uconn.edu\/wp-rest\/wp\/v2\/media\/157578"}],"wp:attachment":[{"href":"https:\/\/today.uconn.edu\/wp-rest\/wp\/v2\/media?parent=158417"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/today.uconn.edu\/wp-rest\/wp\/v2\/categories?post=158417"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/today.uconn.edu\/wp-rest\/wp\/v2\/tags?post=158417"},{"taxonomy":"magazine-issue","embeddable":true,"href":"https:\/\/today.uconn.edu\/wp-rest\/wp\/v2\/magazine-issues?post=158417"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/today.uconn.edu\/wp-rest\/wp\/v2\/coauthors?post=158417"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\nMedImmune
\nIdentifying the Causes for Long Reconstitution Times: Phase III. Exploring the effect of freezing protocol on the porous structure and Tg’ of lyophilized formulations
\n10\/08\/2019 $400,000<\/p>\n
\nDHHS\/NIH\/National Cancer Institute\/NAMI Therapeutics
\nNanoparticle-Based Intraperitoneal Delivery of Combined Chemo-Brachytherapy Corp for Treatment of Ovarian Cancer Metastases
\n12\/03\/2019 $135,643<\/p>\n
\nDHHS\/NIH\/National Institute on Drug Abuse\/Virginia Commonwealth
\nNovel LAAM Formulations to Treat Opioid Use Disorder
\n12\/04\/2019 $443,068<\/p>\n
\nDHHS\/FDA\/Food and Drug Administration\/DigiM
\nMicrostructure characterization with micro-imaging and image-based analytics: a Solution new tool to characterize complex polymer-based long acting drug products
\n12\/06\/2019 $210,001<\/p>\n
\nDHHS\/NIH\/National Heart, Lung, and Blood Institute
\nDeveloping next generation synthetic nucleic acid analogous for sickle cell disease
\n12\/09\/2019 $2,000,300<\/p>\n
\nW. L. Gore & Associates
\nInvestigation of Obstruction of Catheters Used for Intraperitoneal Insulin Delivery
\n01\/20\/2020 $214,500<\/p>\n
\nDOD\/Department of Defense
\nCytoplasmic Suppression of Inflammatory Signaling
\n01\/22\/2020 $322,000<\/p>\n
\nDHHS\/NIH\/National Cancer Institute\/University of Massachusetts Medical School
\nTargeting replication stress avoidance in cancer
\n03\/07\/2020 $75,438<\/p>\n
\nDHHS\/NIH\/National Institute of Allergy and Infectious Diseases\/University of Connecticut Health Center Genetics of HSV DNA Replication
\n03\/13\/2020 $1,028,525<\/p>\n
\nDHHS\/FDA\/Food and Drug Administration
\nImpact of Polymer Attributes on the Performance of In Situ Forming Implants
\n03\/24\/2020 $973,184<\/p>\n
\nPortola Pharmaceuticals\/Hartford Hospital Comparative Effectiveness and Safety of Andexanet Alfa and Four-Factor Prothrombin Eomplex Concentrate in the Management of Oral Factor Xa Inhibitor-Associated Intracranial Hemorrhage: A Pilot Study
\n12\/04\/2019 $138,022<\/p>\n
\nDHHS\/SAMHSA\/Substance Abuse and Mental Health Academic Detailing on Opioid Safety in CT Services Administration\/CT Department of Mental Health and Addiction Services
\n12\/19\/2019 $62,034<\/p>\n